Checklist to assess Trustworthiness in RAndomised Controlled Trials (TRACT checklist): concept proposal and pilot.
Checklist to assess Trustworthiness in RAndomised Controlled Trials (TRACT checklist): concept proposal and pilot.
复制标题
DOI：
10.1186/s41073-023-00130-8
复制
发表时间：
2023-06-20
影响因子：
6.1
通讯作者：
中科院分区：
文献类型：
--
作者：
To propose a checklist that can be used to assess trustworthiness of randomized controlled trials (RCTs). A screening tool was developed using the four-stage approach proposed by Moher et al. This included defining the scope, reviewing the evidence base, suggesting a list of items from piloting, and holding a consensus meeting. The initial checklist was set-up by a core group who had been involved in the assessment of problematic RCTs for several years. We piloted this in a consensus panel of several stakeholders, including health professionals, reviewers, journal editors, policymakers, researchers, and evidence-synthesis specialists. Each member was asked to score three articles with the checklist and the results were then discussed in consensus meetings. The Trustworthiness in RAndomised Clinical Trials (TRACT) checklist includes 19 items organised into seven domains that are applicable to every RCT: 1) Governance, 2) Author Group, 3) Plausibility of Intervention Usage, 4) Timeframe, 5) Drop-out Rates, 6) Baseline Characteristics, and 7) Outcomes. Each item can be answered as either no concerns, some concerns/no information, or major concerns. If a study is assessed and found to have a majority of items rated at a major concern level, then editors, reviewers or evidence synthesizers should consider a more thorough investigation, including assessment of original individual participant data. The TRACT checklist is the first checklist developed specifically to detect trustworthiness issues in RCTs. It might help editors, publishers and researchers to screen for such issues in submitted or published RCTs in a transparent and replicable manner. The online version contains supplementary material available at 10.1186/s41073-023-00130-8.
登录
查看更多内容
影响因子：
2
作者：
Liu, Yizhen;Thornton, Jim G.;Mol, Ben W.
通讯作者：
Mol, Ben W.
DOI：
10.1136/bmj.c332
发表时间：
2010-03-23
期刊：
BMJ (Clinical research ed.)
影响因子：
--
作者：
Schulz KF;Altman DG;Moher D;CONSORT Group
通讯作者：
CONSORT Group
影响因子：
2.9
作者：
Avenell, Alison;Stewart, Fiona;Bolland, Mark
通讯作者：
Bolland, Mark
DOI：
10.1016/j.ejogrb.2021.04.018
发表时间：
2021-05-24
影响因子：
2.6
作者：
Bordewijk, Esmee M.;Li, Wentao;Mol, Ben W.
通讯作者：
Mol, Ben W.
影响因子：
10.7
作者：
Carlisle, J. B.
通讯作者：
Carlisle, J. B.